FDA.reportPublic FDA data

desloratadine 2.5 MG / pseudoephedrine sulfate 120 MG 12HR Extended Release Oral Tablet

RxCUI
1112248
RxNorm name
desloratadine 2.5 MG / pseudoephedrine sulfate 120 MG 12HR Extended Release Oral Tablet
Display name
desloratadine 2.5 MG / pseudoephedrine sulfate 120 MG 12HR Extended Release Oral Tablet
Full name
desloratadine 2.5 MG / pseudoephedrine sulfate 120 MG 12HR Extended Release Oral Tablet
Term type
PSN
Status
DailyMed mapping
Updated
2026-06-04 23:38:49

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
CLARINEX-D 12 HOURDESLORATADINE AND PSEUDOEPHEDRINE SULFATEOrganon LLC1af66b7a-4ab8-40d8-abdd-22d3310228a82025-11-12Warnings, Adverse reactionsExact identifier
rxcui: 1112248

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set IDRxNorm stringTTYSPL versionLabelEffective
1af66b7a-4ab8-40d8-abdd-22d3310228a812 HR desloratadine 2.5 MG / pseudoephedrine sulfate 120 MG Extended Release Oral TabletSCD6These highlights do not include all the information needed to use CLARINEX-D 12 HOUR Extended Release Tablets safely and effectively. See full prescribing information for CLARINEX-D 12 HOUR Extended Release Tablets. CLARINEX-D ® 12 HOUR Extended Release Tablets (desloratadine/pseudoephedrine sulfate) for oral use Initial U.S. Approval: 200520251112
1af66b7a-4ab8-40d8-abdd-22d3310228a8desloratadine 2.5 MG / pseudoephedrine sulfate 120 MG 12HR Extended Release Oral TabletPSN6These highlights do not include all the information needed to use CLARINEX-D 12 HOUR Extended Release Tablets safely and effectively. See full prescribing information for CLARINEX-D 12 HOUR Extended Release Tablets. CLARINEX-D ® 12 HOUR Extended Release Tablets (desloratadine/pseudoephedrine sulfate) for oral use Initial U.S. Approval: 200520251112
c7230a68-a3ac-4dce-9e72-6e21f0b25f4512 HR desloratadine 2.5 MG / pseudoephedrine sulfate 120 MG Extended Release Oral TabletSCD1These highlights do not include all the information needed to use CLARINEX-D ® 12 HOUR Extended Release Tablets safely and effectively. See full prescribing information for CLARINEX-D 12 HOUR Extended Release Tablets. CLARINEX-D 12 HOUR Extended Release Tablets (desloratadine/pseudoephedrine sulfate) for oral use. Initial U.S. Approval: 200520091230
c7230a68-a3ac-4dce-9e72-6e21f0b25f45desloratadine 2.5 MG / pseudoephedrine sulfate 120 MG 12HR Extended Release Oral TabletPSN1These highlights do not include all the information needed to use CLARINEX-D ® 12 HOUR Extended Release Tablets safely and effectively. See full prescribing information for CLARINEX-D 12 HOUR Extended Release Tablets. CLARINEX-D 12 HOUR Extended Release Tablets (desloratadine/pseudoephedrine sulfate) for oral use. Initial U.S. Approval: 200520091230